Merit Medical Systems Inc/ US5898891040 /
2024-06-04 10:00:00 PM | Chg. +0.6100 | Volume | Bid10:00:10 PM | Ask10:00:10 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
82.7900USD | +0.74% | 207,622 Turnover: 10.21 mill. |
59.0000Bid Size: 100 | 84.0500Ask Size: 300 | 4.81 bill.USD | - | 50.45 |
Assets
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 276.5730 | 292.8200 | 331.4520 | 378.7850 | 382.7280 | ||||||
Intangible Assets | - | - | - | - | - | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | 699.3800 | 795.6900 | 1,190.1780 | 1,302.7830 | 1,234.6890 | ||||||
Inventories | 120.6950 | 155.2880 | 197.5360 | 225.6980 | 198.0190 | ||||||
Accounts Receivable | 80.5210 | 105.5360 | 137.1740 | 155.3650 | 146.6410 | ||||||
Cash and Cash Equivalents | 19.1710 | 32.3360 | 67.3590 | 44.3200 | 56.9160 | ||||||
Current Assets | 243.4230 | 316.1210 | 429.8340 | 454.5380 | 429.7070 | ||||||
Total Assets | 942.8030 | 1,111.8110 | 1,620.0120 | 1,757.3210 | 1,664.3960 |
Liabilities
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 30.6190 | 34.9310 | 54.0240 | 54.6230 | 49.8370 | ||||||
Long-term debt | 314.3730 | 259.0130 | 373.1520 | 431.9840 | 343.7220 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 28.2000 | 25.6000 | 59.5000 | 48 | - | ||||||
Liabilities | 444.6140 | 435.4770 | 687.2370 | 807.3770 | 705.8210 | ||||||
Share Capital | 206.1860 | 353.3920 | 571.3830 | 587.0170 | 606.2240 | ||||||
Total Equity | 498.1890 | 676.3340 | 932.7750 | 949.9440 | 958.5750 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 942.8030 | 1,111.8110 | 1,620.0120 | 1,757.3210 | 1,664.3960 |
Income Statement
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 603.8380 | 727.8520 | 882.7530 | 994.8520 | 963.8750 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 34.8760 | 33.0690 | 58.6170 | 15.4340 | -1.5620 | ||||||
Interest Income | -8.7170 | -7.3550 | -9.1610 | -12.4130 | -9.9940 | ||||||
Income Before Taxes | 25.3860 | 35.8810 | 49.5190 | 2.1930 | -13.2310 | ||||||
Income Taxes | 5.2650 | 8.3580 | 7.5020 | -3.2580 | -3.3880 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 20.1210 | 27.5230 | 42.0170 | 5.4510 | -9.8430 |
Per Share
Cash Flow
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 53.5990 | 62.7270 | 86.5330 | 77.8130 | 165.2700 | ||||||
Cash Flow from Investing Activities | -159.1070 | -146.7610 | -378.8200 | -134.4810 | -58.6520 | ||||||
Cash Flow from Financing | 121.0950 | 96.5170 | 328.2800 | 33.5330 | -95.7060 | ||||||
Decrease / Increase in Cash | 14.9940 | 13.1650 | 35.0230 | -23.0390 | 12.5960 | ||||||
Employees | 4,150 | 4,876 | 5,783 | 6,355 | - |